Handwriting Rehabilitation in Parkinson Disease (HRPD)
Effectiveness of Intensive Handwriting Rehabilitation in Subjects With Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Paola Ortelli, PsyD
- Phone Number: +393332974872
- Email: ortellipaola73@gmail.com
Study Locations
-
-
Como
-
Gravedona ed Uniti, Como, Italy, 22015
- Recruiting
- Ospedale Generale di Zona Moriggia Pelascini
-
Contact:
- Paola Ortelli, PsyD
- Phone Number: +393332974872
- Email: ortellipaola73@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parkinson's Disease patients
Exclusion Criteria:
- Mini Mental State Examination (MMSE) score < 24
- Left handed subjects
- Subjects with dyskinesias
- Subjects with Deep Brain Stimulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Group 1 - Writing with 1 cm cue
This group uses to write space of 1 cm size
|
Writing exercise with or without cues for 1 hour per day for 4 days at week for 4 weeks
|
|
EXPERIMENTAL: Group 2 - Writing with 1.5 cm cue
This group uses to write space of 1.5 cm size
|
Writing exercise with or without cues for 1 hour per day for 4 days at week for 4 weeks
|
|
EXPERIMENTAL: Group 3 - Writing without cue
This group writes without using cues
|
Writing exercise with or without cues for 1 hour per day for 4 days at week for 4 weeks
|
|
NO_INTERVENTION: Group 4 - no writing
This group do not write.
Only wrist mobilization is performed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
letters size
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
writing speed (time spent to write every single letter and word, measured in milliseconds)
Time Frame: 4 weeks
|
4 weeks
|
|
centimeters away from a straight line during writing
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Giuseppe Frazzitta, MD, Ospedale Generale Di Zona Moriggia-Pelascini
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Handwriting rehab in PD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.